About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in Houston | 110 Studies

Clinical Trials LupusHouston

Lupus Clinical Trials in Houston

Find 110 clinical trials for lupus near Houston, Texas. Connect with research centers in your area.

All Lupus trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 110 trials

CompletedEfficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy and safety of an intravenous treatment regimen of anifrolumab versus placebo in adult participants with moderately to…NCT02446899·Covina, California and 112 others

Page 1 of 6Next

Lupus Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of KZR-616 in Patients With SLE With and Without Lupus NephritisThis was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).NCT03393013·Los Angeles, California and 35 others

CompletedEfficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy and safety of an intravenous treatment regimen of two doses of anifrolumab versus placebo in adult subjects with moderately…NCT02446912·Birmingham, Alabama and 144 others

CompletedSafety of Estrogens in Lupus: Birth Control PillsSafety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether women with systemic lupus erythematosus (SLE or lupus) can safely use estrogen.NCT00000420·Los Angeles, California and 14 others

Active not recruitingA Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE)…NCT05617677·Birmingham, Alabama and 196 others

CompletedFeasibility and Performance of a Structured Video Telemedicine Program in Patients With Systemic Lupus ErythematousThis study seeks to determine the feasibility, effectiveness and safety of a structured video telemedicine program for the treatment of patients with systemic lupus erythematous…NCT07840573·Houston, Texas

CompletedA Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years OldIn this study, researchers will learn more about the use of felzartamab in people with active lupus nephritis, also known as LN.NCT06064929·La Jolla, California and 23 others

CompletedEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to determine if Rozibafusp Alfa could be a useful therapeutic agent in the current treatment landscape where subjects with SLE have ongoing disease…NCT04058028·Birmingham, Alabama and 146 others

CompletedSafety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) LesionsThe purpose of this study is to determine the safety, efficacy and tolerability of topical R333 ointment in Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus…NCT01597050·Los Angeles, California and 14 others

CompletedA Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin ManifestationsThis study will be conducted to characterize pharmacokinetics, pharmacodynamics, safety, and tolerability of anifrolumab given via the subcutaneous (SC) route of administration in…NCT02962960·Thousand Oaks, California and 13 others

CompletedA Study of LY2127399 in Participants With Systemic Lupus ErythematosusThe purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two different doses of LY2127399 administered in participants with active SLE.NCT01196091·Birmingham, Alabama and 191 others

RecruitingStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VThe overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.NCT05268289·Phoenix, Arizona and 102 others

TerminatedAscension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint ProsthesisThis study is a non-randomized, consecutive enrollment, one-year post-approval study of patients who are treated with the Ascension® MCP.NCT02408471·Tucson, Arizona and 8 others

CompletedAn Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus ErythematosusThis study will investigate BMS-986165 to assess its effects in participants with systemic lupus erythematosus (SLE).NCT03252587·Birmingham, Alabama and 191 others

CompletedSubcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus ErythematosusThe objective of this study is to evaluate and compare efficacy of 3 dose levels of PF-04236921 to placebo in subjects with generalized lupus using a measure called the Systemic…NCT01405196·Anniston, Alabama and 112 others

CompletedEG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety StudyNeuropsychiatric systemic lupus erythematosus with cognitive impairment (NPSLE-CI) is a serious, disabling, and potentially life-threatening manifestation of SLE, affecting up to…NCT07281105·Cleveland, Ohio and 2 others

CompletedA Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the efficacy, safety and tolerability of belimumab administered subcutaneously (SC) to adult subjects with Systemic Lupus Erythematosus…NCT01484496·Birmingham, Alabama and 206 others

Enrolling by invitationLong-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus ErythematosusThe goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe symptoms of systemic lupus…NCT06475742·Aurora, Colorado and 121 others

TerminatedEfficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)The purpose of this study is to evaluate the efficacy and safety of MK-6194 in adult participants with systemic lupus erythematosus.NCT06161116·Covina, California and 126 others

CompletedA Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an AutoinjectorThe primary objective of this study is to assess the suitability of the autoinjector for self-administration of belimumab by subjects with SLE in real-life conditions.NCT02124798·Birmingham, Alabama and 26 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia